08/03/2009 • Focus on Products at Analytica

Non-Invasive Prenatal Diagnostics

Qiagen announced the launch of a product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. Scientists consider these DNA and RNA fragments to have great potential for the highly sensitive and non-invasive diagnosis of a wide range of diseases, including congenital disorders, malignancies such as colon and lung cancer, and infections. The QIAamp Circulating Nucleic Acid Kit is expected to significantly facilitate the corresponding biomarker research and the introduction of novel molecular tests in prenatal diagnostics, which can replace risky, invasive procedures such as amniocentesis. Free circulating DNA and RNA fragments are found in body fluids such as plasma, serum and urine.

This product information
is expired!

Use our search-function for current products ...
gradient arrows

QIAGEN GmbH

Qiagen Straße 1
40724 Hilden

Phone: +49 (0) 2103/ 29- 0
Fax: +49 (0) 2103/ 29- 22022